Data from the survey will be used as a comparison to previous years (2019 and 2020), to determine whether the changes in puppy buying in the UK seen during the COVID-19 pandemic have returned to their pre-pandemic baseline or persisted into 2021.
Dr Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science at the RVC said: “The COVID-19 pandemic led to changes in the way many of us bought our household goods, with online ordering and delivery a common feature of lockdown life.
"The pandemic also led to changes in the way the UK bought puppies during 2020, due to the many restrictions to travel and social contact during this period.
"Many of these so-called ‘Pandemic Puppies’ became much-cherished companions, helping households cope with lockdown life; however, there are concerns that some owners were duped into buying from unscrupulous breeders.
"We are interested in whether pandemic-related changes in puppy buying persisted into 2021, so we can best support owners of puppies bought during this period going forward."
For more information, visit: www.rvc.uk.com/Pandemic-Puppies-of-2021-research
The survey is at: www.rvc.uk.com/Puppy2021-survey
To celebrate the launch of its brand new keep reproduction simple advertisement campaign, CEVA Animal Health is giving British Cattle Veterinary Association (BCVA) Congress delegates the chance to win an iPod by entering a special spot the sperm competition.
BCVA Congress runs from 26-28 November 2009 in Southport. Delegates just need to spot five sperm lurking in the banner-sized cartoon for CEVA's GnRH product Ovarelin®. The correct answers will be entered into a draw to win an iPod.
The company says its new ad campaign brings together a series of cartoons with a clever play on words to highlight the importance of a simple protocol for success with reproduction. You can follow this irresistibull series in the farm media throughout the autumn.
For further information contact your local CEVA representative or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, www.ceva.uk.com
Veterinary training provider Improve International has opened training facilities at its new European head office, near Swindon.
The company says its relocation to Alexandra House Conference Centre is a strategic move, allowing it to offer residential courses, new programmes and extended courses, as it challenges the industry to re-think its approach to Continuous Professional Development (CPD) and postgraduate qualifications.
Nick Fowler, General Manager of Improve International said: "As a training company founded by vets for vets, we want to harness the passion and experience which can be found throughout the profession and nurture a desire for lifelong learning.
"Training shouldn't become a CPD 'tickbox' that's cumbersome to fit around practice commitments. That's why we have moved towards a far more flexible modular programme, where we can design a personal development plan around an individual's career aspirations - whether they are vets in general practice, vets with special interests, a veterinary nurse, or a practice manager.
"Having the very best facilities in which to train is integral to this plan, so having outgrown our centre in Cricklade, we were keen to find new premises which would meet all our needs. Although it's an unusual scenario to move into an established conference and events centre, we felt that the facilities offered by Alexandra House - from the fully serviced training rooms to the uniquely designed practical suite, 5 star bedrooms, acres of grounds, on-site leisure complex and great food - would all enhance the training experience of our delegates."
A separate wing of Alexandra House has been converted into Improve International's office space, training rooms and a 700 square feet state-of-the-art practical facility which the company says will be one of the finest available in Europe.
Improve International will open a second sister centre at Cranage Hall in Cheshire, also part of the Principal Hayley conference group, within the next 12-months.
Information about courses and facilities is available at www.improvecpd.com
Two vacancies have arisen for veterinary surgeons to join the Royal College of Veterinary Surgeons' Veterinary Nurses Council.
The positions, which are open to veterinary surgeons not currently serving on RCVS Council, would be particularly well suited to those veterinary surgeons who have an interest in the nursing profession and some experience of working with nurses. However, applicants need not necessarily be politically involved with the profession at this point.
VN Council Chairman Liz Branscombe said: "Veterinary nurses play a vital role in the practice team and, with the opening of the non-statutory Register in 2007, the VN profession is now recognising its responsibilities in terms of maintaining professional standards, skills and competence.
"Now, more than ever, it is important that vets from all sectors of the profession take the time to get involved with the regulation and development of the role of the veterinary nurse."
Applications are invited from all veterinary surgeons, although those with some experience of working with veterinary nurses would be most relevant.
The four-year posts will require an annual time commitment of approximately six to ten days.
For an application pack, please contact Annette Amato, Deputy Head of Veterinary Nursing, on 020 7202 0713 or a.amato@rcvs.org.uk. The deadline for the receipt by RCVS of completed application packs is 30 April 2011.
Novartis Animal Health has launched a new website providing product information, news, up to date advice and insights into key issues facing the farming industry.
Nikki Crossley, Associate Brand Manager at Novartis Animal Health, said: "This new site is set to offer our customers a fantastic new resource and learning space as well as an opportunity to interact with us as a company. We aim to provide a service which is not typically associated with animal health companies and bring key elements of the industry closer together."
Farmers, vets and SQPs are invited to register at: http://www.farmanimalhealth.co.uk/.
Invicta Animal Health has launched an enhanced version of the ChroMyco Duo dermatophyte test.
The tests use a new round plate with an improved lid design. In addition, the plates are wider and deeper providing 25% more culture medium.
According to the company, the dual plate test with Dermatophyte Test Media (DTM) on one side and an Enhanced Sporulation Agar (ESA) on the other greatly reduces the risk of false positive results.
The test is performed by veterinary staff taking a pluck of fur or skin scrape from the lesion and inoculating both sides. After three to six days of room temperature incubation, if dermatophytes are present, the DTM will turn red and the ESA will turn blue-green.
Rob Watkins, Managing Director of Invicta, said: "We always listen and respond to customer feedback. The new design plates provide reduced condensation levels and by being easier to inoculate will enhance the usability and hence reliability of the test."
The price remains unchanged at £32.00 for 5 tests, from veterinary wholesalers.
For more information call 01403 791313 or email mail@invictavet.com.
Taking over from Carl Gorman, Julian says his focus is to continue the work undertaken this year as part of a ‘programme of change’ for BSAVA, that will continue to promote the strong sense of community within the membership and the wider profession.
Speaking at the BSAVA AGM, Julian said: “I am very humbled as I stand here today as your 67th President. It is certainly the pinnacle of my veterinary career, and the greatest honour yet bestowed on me in life.
"We continue to live in exciting times at BSAVA, and as ever, I join a team of utterly amazing staff at Woodrow House.
“I really do believe that the BSAVA will continue to go from strength to strength and will continue to maintain its relevance and position as the indispensable voice of the small animal veterinary profession.”
Julian started volunteering for the BSAVA after his graduation within the Southeastern Regional committee, becoming Chair of the committee after a few years.
He then became part of the BSAVA Education Committee, BSAVA PetSavers Grants Awarding Committee, and was lately part of the Publications Committee.
He then joined the Presidential ladder two years ago as Junior Vice President.
Outside of his volunteering for the BSAVA, he was at Crossways Vets in West Sussex for 17 years, initially as a partner, then as an owner, and finally as a Clinical Director.
He has since stepped down from the practice to devote his time to being BSAVA President this year.
Medivet has announced the appointment of John Bower MBE BVSc MRCVS to its Panel of Enquiry set up following coverage of the company on Panorama.
Mr Bower has been President of the British Veterinary Association, the British Small Animal Veterinary Association, and the Veterinary Practice Management Association.
Mr Bower said: "Medivet is a large partnership with numerous branches and I am looking forward to helping the partners assess and review the management of their practice to eliminate the sort of incidents and situations that were alleged in the Panorama programme. This panel will look deeply into the management and I have been convinced by the partners that they are determined to take appropriate measures where necessary."
Adi Nell, Medivet central partner and fellow member of the panel said: "We are delighted that John Bower is to be a part of our panel. John is not only an eminent vet of unquestionable ethical standing, but he set up and ran a medium-sized veterinary partnership for 38 years. His expertise will be crucial to Medivet, as the panel carries out its investigations and makes its recommendations over the next few months."
Mr Bower, who retired from general practice in 2007, is currently Veterinary Advisor to Petplan Insurance Company and a trustee of two national charities - Hearing Dogs for Deaf People and The Petplan Charitable Trust. Mr Bower was awarded the BSAVA Melton Award for meritorious contributions to Small Animal Practice in 1991, the MBE in 2010 for services to the BVA:AWF, and has authored or co-authored a number of books including Veterinary Practice Management, The Dog Owner's Veterinary Handbook and The Cat Owner's Veterinary Handbook.
The Veterinary Karting Championship, organised by NVS, is proving a huge success, according to the company. At the half way stage of the championship, around two hundred drivers have already participated in regional events in Manchester, Edinburgh, Essex, Surrey and Reading.
Drivers arrive following evening surgery and change from veterinary uniforms into their race suits. All drivers receive race and safety briefings before heading off to meet their team mates and get a feel for the track during the practise session.
Racing lasts for an hour and a half, during which time teams have to use clever strategies and tactics to remain in pole position and avoid eviction from the track for foul play. At the end of the evening, all competitors get a goody bag and jacket, with each member of the winning team receiving a bottle of champagne, a trophy and certificate.
Caitrina Harrison, Sales & Marketing Director at National Veterinary Services, said: "All the evenings have been great fun and have certainly shown the competitive side of the veterinary profession. The ladies have definitely given the men a run for their money, especially in Scotland. Some drivers have been so inspired by the events that they are looking to host their own inter-practice championships next year."
The teams that have qualified so far for the National Final are: Manchester Bears, Essex Panthers, Scottish Bears (pictured), Reading Bears and Camberley Elks. There will be a break from racing over the festive period, with the next regional heat taking place in Bristol on Tuesday 18th January. Further heats will then be held in Birmingham, Loughborough, Aylesbury and Leeds, followed by the National Final on Sunday 20thMarch in Milton Keynes.
Caitrina Harrison continues: "NVS would like to thank the event sponsors for their support, which has been invaluable in making the championship happen. The championship sponsors are Agria Pet Insurance, Hill's Pet Nutrition, Dechra
Merial, the manufacturer of FRONTLINE Combo, FRONTLINE Spot On and Merilym3 has announced that Bill Oddie will front its autumn 'Be Tick Aware' PR campaign to highlight the importance of protecting pets from ticks.
The campaign will run throughout September and into October to drive awareness via print, broadcast and digital media.
Merial says the campaign has been designed to raise awareness of ticks and tick-borne diseases amongst vets, pharmacists and SQPs and in turn to educate pet owners on the importance of regularly treating their pets for ticks.
The company is also continuing its partnership with BADA-UK, the tick-borne disease charity whose own demonstration dog, Shaun, recently suffered with Borreliosis (Lyme disease).
BADA-UK founder and Chair, Wendy Fox, said: "The infection highlights the very real risk of contracting tick borne diseases, even for the most well-cared for dogs and tick-aware owners. We find a lot of owners genuinely believe their dogs cannot get ticks because they keep their animals clean and well groomed. This sort of misconception is notable even at canine events where you might expect to encounter the best informed dog owners, but the sad fact is many people still do not take the risk of tick-borne diseases seriously enough."
Roddy Webster Head of Pets UK from Merial said: "It is a pleasure to work with Bill Oddie, a fellow animal lover and expert, to highlight the risk of ticks this autumn. Ticks and tick-borne diseases are an increasing threat, and the risk in the UK is rising. Ticks are considered to be second only to mosquitoes as vectors of infectious diseases around the world. Disease-transmitting ticks can be found anywhere - gardens, forests, parks and even beaches. This campaign is designed to encourage vets, pharmacists and SQPs to educate their clients and customers about ticks, the dangers of tick-borne disease and the importance of regular tick prevention. We're extremely excited about this campaign and we're looking forward to seeing the positive effects."
All existing BEVA members will have their membership automatically extended until 30 June 2020. The association is also inviting vets and vet nurses who are not already BEVA members to join as online members free of charge until 30 June 2020.
BEVA President Tim Mair said: “In this extraordinary time of global crisis our profession, as with many industries, is under immense pressure. By offering free membership we are giving equine vets easy access to a wealth of supportive resources and online CPD to help them through these dark times.”
BEVA membership includes:
The association is also looking at other ways to support the profession, which has included making all BEVA Congress 2019 webinars available to members via the BEVA online learning platform.
To sign up from Monday 30 March 2020 visit: https://www.beva.org.uk/Join-BEVA
Every year, the RCVS invites members of the veterinary profession to apply to join the RCVS Fellowship.
Becoming a member of the Fellowship is a recognition of an individual’s contribution to the professions and their commitment to advancing the scientific achievements of the veterinary sector.
Everyone that applies to join the Fellowship needs to demonstrate the impact they have had throughout their career on the veterinary professions.
The Fellowship Credentials Panel is responsible for reviewing and scoring Fellowship applications and making recommendations for who should be approved.
Angharad Belcher, Director for Advancement of the Professions, said: “Being part of our Fellowship Credentials Panel is a great opportunity to see the huge amount of dedication to the profession that prospective Fellows have shown throughout their careers, and to then celebrate their achievements when they are successfully welcomed to the Fellowship later in the year”.
To apply to join the Fellowship Credentials Panel, download and complete the application form (https://www.rcvs.org.uk/fellowship/credentials-panel-recruitment-2022/), then email it to Ceri Chick, Senior Leadership Officer at c.chick@rcvs.org.uk with a CV by 5pm on 28 February 2022.
This brings the total reported the UK so far this year to eight, following 28 last year and 287 in total.
For a map of all confirmed cases and information for veterinary professionals and pet owners about CRGV, visit: www.alabama-rot.co.uk.
All entrants to the survey will also be able to enter a draw to win a £50 Amazon voucher.
Jenny Langridge (pictured), Editor of Veterinary Woman, said: “This is our third annual survey and we are seeking the opinions of both Veterinary Woman readers and the wider professions to highlight the key issues affecting women in the veterinary sector.
"We’re not just asking questions, we’re offering veterinary professionals a chance to take part in an ongoing conversation about the very real issues that women face in the veterinary workplace.
"The more diverse the information we can collate about these topics, the more we can work towards achieving changes that help for women to thrive in the professions.”
All data and responses will remain strictly anonymous.
https://bit.ly/vet-woman-readership-survey
Programme highlights for BVA Live this year include:
British Veterinary Association President Anna Judson said: “This has been an incredibly challenging year for the profession, with the review by the Competitions and Marketing Authority (CMA) prompting increased scrutiny of the value of veterinary care.
"We know that all veterinary professionals strive to provide the best possible care for the animals they see and we hope our focus on contextualised care at BVA Live provides a timely opportunity to explore this concept in more depth and consider how it can be applied in practice to support both decision-making and communication with clients.”
https://bvalive.vetshow.com
Dechra Pharmaceuticals has signed an agreement with Piedmont Pharmaceuticals LLC which gives Dechra exclusive worldwide rights to the sale and distribution of veterinary products which use Piedmont's proprietary soft chew platform to deliver the active ingredient.
The agreement will allow Dechra to conduct studies necessary to achieve regulatory filings and government approvals within the US, Europe and other key countries.
According to Dechra, Piedmont's soft chew formulation is a unique delivery technology which overcomes the traditional problems in formulating a broad range of active drug compounds in a highly palatable chewy treat for both cats and dogs.
Ian Page, CEO of Dechra Pharmaceuticals PLC, said: "We are very excited about licensing this unique delivery technology, which will be the first soft chew product with this new patent pending technology in the veterinary market. The agreement will provide Dechra with the opportunity to expand our presence in the companion animal market with a truly differentiated product."Roland Johnson, Chairman and CEO of Piedmont Pharmaceuticals, said: "This is our initial development partnership for our soft chew technology and we welcome the opportunity to license our technology to Dechra. Our goal is to provide pet owners the added benefit of a tasty treat at medicine time, creating a fun and rewarding interaction, while improving compliance with the vet prescribed treatment regimen."
B&W Equine Group has opened a brand new, state-of-the-art equine clinic at Breadstone in Gloucestershire.
The new facility opened on 1 October 2011. It cost over £2.2 million and is, according to the company, one Europe’s most advanced diagnostic and surgical centres.
B&W Equine Group was created in 2008, following a merger between Willesley Equine Clinic and Bushy Equine Vets. The 23 vet practice has four local equine clinics in Breadstone, Cardiff, Failand and Willesley.
The new clinic, located on a four acre site at Breadstone, close to the M4 and M5 intersections, provides state-of-the-art diagnostics and advanced laboratory facilities. It houses the only equine MRI scanner in Wales and the South West, as well as a CT scanner and scintigraphy unit. Orthopaedic and colic theatres, adult and neonatal intensive care suites and separate isolation units have all been custom-designed and are supported by five examination rooms and two knock down boxes.
Clinical and referral services are led by RCVS and European Recognised Specialists in surgery, orthopaedics, diagnostic imaging and internal medicine and include gynaecological management of breeding mares and pre-season disease screening. The on-site laboratory is one of only 30 in the UK to be certified by the HBLB to test for CEM and EVA.
Ian Camm, BVSc CertEP MRCVS, Group Director, said: “We are all extremely excited about the new clinic but our day-to-day first opinion work remains a top priority. For all our local clients it’s very much a case of business as usual but the fact that we have invested in the latest portable equipment, including video endoscopes, digital radiography and ultrasound scanners, means we can undertake more specialist work at client’s yards, as and when needed.”
For further information, visit www.bwequinevets.co.uk.
Dechra Veterinary Products has launched www.canine-cushings.co.uk, a new website for owners of dogs with Cushing’s syndrome, to support the advice given by their veterinary surgeon.
The new site contains information and resources designed to support dog owners whose pets have been prescribed Vetoryl. It looks at symptoms, diagnosis and treatment options, and owners can register for interactive treatment log book.
Craig Sankey, Brand Manager at Dechra Veterinary Products, said: "Diagnosis can be worrying for owners and the aim of the website is to help increase knowledge surrounding Cushing’s syndrome.
"The interactive treatment log book can be used by owners to chart progress and provide reassurance about how their dog is responding to Vetoryl therapy."
The survey asks EU nationals about their experience of practising in the UK since the referendum and will seek to find out what their career expectations and aspirations are now.
The survey will also ask how they feel that the RCVS has supported EU vets to practise in the UK since the transition period ended on 31 December 2020.
The survey is being conducted by the Institute for Employment Studies (IES), an independent, not-for-profit research institute.
Respondents are encouraged to be as open as possible, as individual responses will not be seen by the RCVS and all survey data will be analysed independently by IES.
Lizzie Lockett, RCVS CEO said: “We are hearing anecdotal feedback from EU veterinary professionals about the impact of the EU Exit on their working lives, but it is important for us to have direct feedback as evidence for our recommendations.
"I would encourage everyone who receives the survey to share their thoughts with us, as the feedback we receive from this and the previous surveys, will help us to plan what training, resources and support the professions need from us post-EU Exit."
Everyone eligible to take part in the survey is being sent an email today from Dilys Robinson at the IES, with a link to the survey.
You have until Tuesday 16th November 2021 to complete it.
If you have any questions, contact Sara.Butcher@employment-studies.co.uk.
Life Technologies Animal Health has announced the launch of a new qPCR test to improve the diagnosis of mastitis and respiratory disease caused by Mycoplasma bovis.
According to the company, the TaqVet Mycoplasma Bovis (M. bovis) polymerase chain reaction (PCR) kit is based on a new target gene in the M. bovis genome and thus can distinguish better between infections caused by M. bovis and M. agalactiae - so there is less risk of false positive results and improved sensitivity and specificity.
The test is based on real-time PCR technology, and delivers results in two and a half hours.
Eric Sellal, Head of Animal Health EMEA at Life Technologies said: "The improved sensitivity of this new test means that veterinarians will be able to monitor dairy herds for sub-clinical infection using samples from the bulk tank. And of course it can also be used to diagnose mycoplasma infection in individual cases of clinical mastitis and respiratory disease."
Life Technologies says the test system incorporates a number of other improvements which simplify and speed up processing in the laboratory, including automatic extraction using magnetic bead technology.
It is estimated that bovine pneumonia costs the European industry around 500million Euros each year, with 30% accounted for by M. bovis. Other diseases associated with the organism include mastitis and arthritis.
Mycoplasma is slow and difficult to culture in the laboratory and current antibiotic treatment is not very cost-effective. Therefore, prevention is a cornerstone of M. bovis management.
The TaqVet Mycoplasma Bovis PCR kit will be made available in other EU countries and via Life Technologies Animal Health distributors according to local regulatory requirements (see www.lifetechnologies.com/lsi-animal-health) for details.
White Cross Vets, a group with 11 surgeries in the Midlands and the North of England, has picked up two Veterinary Marketing Association awards at an event usually dominated entirely by big pharma.
The group was joint winner of Public Relations Award, alongside Bayer Animal Health.
White Cross Marketing Manager Justin Phillips also walked off with the Young Marketeer of the Year award, fighting off competition from Elizabeth Rawlings from Dechra and Beverly Hammond from Animalcare Ltd.
The practice group won the PR Award for a campaign in which it managed to generate a massive amount of media coverage for the business primarily by spotting a good opportunity, and acting quickly to make the most of it.
The story began last July, when a man spotted an exotic-looking bird walking around Guisely, near Leeds. When he tried to capture the bird, it told him to 'bugger off'. Undeterred, he picked it up and took it to White Cross Vets. Once the vets had examined the bird to make sure it was in good health, White Cross instructed its PR agency to begin a media campaign to reunite the animal with its owner. The resultant story generated over £145,000 worth of branded coverage in local and national media, including the Daily Mirror, Metro, the Yorkshire Post and ITV.
By contrast, Bayer Animal Health's winning campaign, which ingeniously used LED lights strapped to snails to bring the lungworm story to life, was nevertheless the product of month's of planning and what would have been a considerable budget.
The judges felt both entries were impressive in completely different ways, so a draw was the only option.
Picture shows, left to right: Heidi Bruckland (Pegasus), Emma Swain (Pegasus), Helen Moore (Markettiers4DC), Marcus Edingloh (Bayer), Luke Hopkins (Pegasus), Caroline Braidwood (Bayer); Jane Manning (Splash); Tim Harrison (White Cross Vets); Justin Phillips (White Cross Vets)
This year's National Equine Health Survey, conducted by the Blue Cross and supported by Zoetis, has revealed that 20% of owners who claimed to have treated for encysted small redworm (ESRW) used a wormer that was not indicated to treat the parasite.
3,669 horse owners took part in the survey, which was conducted in May 2014. It contained 25 questions on general horse health, care and management and was validated by Professor Josh Slater at the Royal Veterinary College.
Zoetis says the findings suggest that horses are being left at serious risk (untreated, encysted small redworm may develop and emerge en masse from the gut wall, causing diarrhoea and colic with a mortality rate of up to 50%1).
The company is now running an encysted small redworm awareness campaign at www.esrw.co.uk, where owners can test their knowledge before discussing the best treatment options with their vet.
References
1. Dowdall S.M.J. et al (2002) Veterinary Parasitology 106, 225‑242
The webinar is presented by Will Stirling, partner at VetsDigital, a digital marketing agency which supports the veterinary industry across Europe.
Will will offer practical advice and guidance on the growing importance of applying digital marketing and the effect it can have on both team morale and the bottom line.
To register for the webinar, visit to: https://tinyl.io/5aIi
Invetx specialises in developing protein-based therapeutics for chronic conditions in companion animals, with a focus on monoclonal antibodies (mAbs).
Dechra says these therapies have targeted modes of action and therefore are often more effective, provide an extended duration of activity and have fewer side effects, all of which help to extend and improve the quality of life for companion animals while decreasing the care burden for pet owners.
Jesper Nordengaard, Chief Executive Officer of Dechra, said: "I regard this acquisition as hugely important for Dechra, marking the start of a new chapter in our growth.
"It demonstrates our ambition to create further points of differentiation and relevance with veterinarians and pet owners alike, confidence in our ability to deliver highly innovative new products, and capacity to execute large scale transactions at speed."
Jesper added: “The half-life extension technology developed by Invetx allows for the generation of therapeutics that make treatment of chronic conditions far more convenient for pet owners and veterinarians through improved compliance.
"The pipeline of products currently being developed are all high value potential and will deepen our expertise in core therapeutic areas such as atopic dermatitis and osteoarthritis, allowing for synergistic product development, sales & marketing, and education efforts in the future.”
https://www.invetx.com
The Elekta Infinity linear accelerator is the only one of its kind for pets in England.
CVS says it allowing the centre to offer “cutting edge” image-guided radiation treatments for cancer in cats and dogs – meaning fewer, shorter sessions, fewer side effects and the best possible chance of improved outcomes for the animal.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our new hospital is now at the forefront of cancer care in animals.
"We have invested in this state-of-the-art technology to bring cancer treatment in pets to the next level.
“Our unique linear accelerator allows us to offer advanced image-guided treatments - for example intensity-modulated or stereotactic radiation therapy.
"The advantage of these treatments is that high dose rates of focused beams are delivered with high precision over a shortened treatment course, with greater safety for the patient’s healthy tissue.
“It has now drawn many tumours into the realm of treatability, it is improving the quality of life for patients, and it is making it easier for owners to manage their pet’s treatment and aftercare.”
Still, the installation of the linear accelerator will probably have cost the same again, and then you've got the running costs.
That's not an inconsiderable cost per patient.